MaxCyte Inc (LSE:MXCT) - Share price - Overview

Stock Report

MaxCyte Inc MXCT

Last Price
GBX245.00

Day Change
-2.50|-1.01%

As of 18/08/2017
16:35:01 BST | GBX
Minimum 15 Minutes Delay.

Last Close247.50p
Day Range240.00 - 240.00
Mkt Cap124.60Mil
52-Wk Range83.00 - 305.00
Yield %0.00
ISINUS57777K1060
Volume1,500
P/E-30.39
P/S9.03
P/CF-47.49

Share Price

Total Returns 21/08/2017

 Chg (%)  
More ...
MaxCyte Inc0.00 
FTSE 100 TR GBP-0.08
 
Financials
201420152016
More ...
Income Statement
Turnover4.606.089.09
Operating Profit-0.82-0.50-2.02
Net Profit-1.18-0.95-2.48
Reported EPS-5.53-5.30-8.15
Balance Sheet
Current Assets3.824.2012.78
Non Current Assets0.150.140.23
Total Assets3.974.3413.01
Current Liabilities2.703.454.58
Total Liabilities33.1437.158.89
Total Equity-29.17-32.814.11
Cash Flow
Operating Cash Flow-1.24-0.12-1.73
Net Change in Cash1.70-0.656.90
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-8.60-17.36--14.12---
2018-10.54-20.69--11.84---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
20/10/2016PurchaseMr. John Johnston96.0037,50036,000.00
19/10/2016PurchaseMr. John Johnston98.0037,50036,750.00

Company Profile

MaxCyte Inc is a provider of technological solutions to pharmaceutical companies. Its key product is electroporation technology which is sold to companies which are engaged in drug discovery and development.

Sector

Diagnostics & Research

Market Position

856 of 1847 Companies

Index

Outlook

(12/07/2017) "...remains strongly positioned for continued growth"

Next Event 29/09/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-12.5813.6616.75
Div Yld (E)0.004.094.23
PEG (E)0.000.631.09
ROCE-24.21184.31202.59
Op Mrgn-21.75-6.30-106.21
EPS Grwth0.0027.9323.10
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. J. Thompson
Chief Financial Officer & Company SecretMr. Ron Holtz
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.